Literature DB >> 28364348

Analysis of soluble factors in conditioned media derived from primary cultures of cirrhotic liver of biliary atresia.

Taisuke Yamazaki1, Mariko Wakai2, Shin Enosawa3, Takayoshi Tokiwa2.   

Abstract

Biliary atresia (BA) is a rare and serious liver disease in newborn infants. Previously, we reported that non-parenchymal cell (NPC) fractions from cirrhotic liver of BA may contain hepatic stem/progenitor cells in primary culture of NPC fractions. In this study, NPC fractions were subjected to primary or passage culture and found that clusters of hepatocyte-like cells appear even without adding hepatocyte growth factor (HGF) to the culture medium, but not in their passage culture used as a control. Based on these findings, conditioned media (CMs) were collected and soluble factors in the CMs were analyzed in order to elucidate the mechanism of the appearance of hepatocyte-like cells or their clusters. A large amount of active HGF consisting of α and β chains was detected in CMs derived from primary culture, but not in CMs from passage culture, as determined by western blot analysis, bone morphogenetic protein (BMP)-4, oncostatin M (OSM), and transforming growth factor (TGF)-β1 were not detected in any of the CMs. The number of hepatocyte-like cells in primary culture tended to decrease following treatment with the HGF receptor c-Met inhibitor, SU11274 in a dose-dependent manner. Furthermore, the clusters of hepatocyte-like cells tended to increase in size and number when freshly isolated NPC fractions were cultured in the presence of 10% of CMs collected after 3-4 wk of primary culture. In conclusion, these findings indicate that CMs derived from primary culture of NPC fractions of BA liver contain a large amount of active HGF, which may activate hepatic stem/progenitor cells and promote the appearance of hepatocyte-like cells or their clusters through HGF/c-Met signaling. The present study would lead to cell therapy using the patient's own cells for the treatment of BA.

Entities:  

Keywords:  Active HGF; Biliary atresia; Hepatocyte-like cells; Non-parenchymal cell fractions; Soluble factors

Mesh:

Substances:

Year:  2017        PMID: 28364348     DOI: 10.1007/s11626-017-0144-3

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  25 in total

1.  SV40 large T antigen immortalization of rat hepatic stellate-like cells.

Authors:  T Tokiwa; Y Yata; T Takahara; A Watanabe; S Enosawa; S Suzuki; J Kano; M Noguchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-05       Impact factor: 2.416

2.  A comparison of the chemical and liver extract-induced hepatic differentiation of adipose derived stem cells.

Authors:  Truong Hai Nhung; Nguyen Hai Nam; Nguyen Thi Kim Nguyen; Huynh Nghia; Nguyen Van Thanh; Phan Kim Ngoc; Phuc Van Pham
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-08-15       Impact factor: 2.416

3.  Isolation and characterization of a stem cell population from adult human liver.

Authors:  Maria Beatriz Herrera; Stefania Bruno; Stefano Buttiglieri; Ciro Tetta; Stefano Gatti; Maria Chiara Deregibus; Benedetta Bussolati; Giovanni Camussi
Journal:  Stem Cells       Date:  2006-08-31       Impact factor: 6.277

4.  The mixed coculture effect of primary rat hepatocytes and bone marrow cells is caused by soluble factors derived from bone marrow cells.

Authors:  Hiroyuki Ijima; Takeshi Matsuo; Koei Kawakami
Journal:  J Biosci Bioeng       Date:  2008-03       Impact factor: 2.894

5.  Comparative study of mouse and human feeder cells for human embryonic stem cells.

Authors:  Livia Eiselleova; Iveta Peterkova; Jakub Neradil; Iva Slaninova; Ales Hampl; Petr Dvorak
Journal:  Int J Dev Biol       Date:  2008       Impact factor: 2.203

6.  FGF4 and HGF promote differentiation of mouse bone marrow mesenchymal stem cells into hepatocytes via the MAPK pathway.

Authors:  T Lu; C Yang; H Sun; J Lv; F Zhang; X J Dong
Journal:  Genet Mol Res       Date:  2014-01-21

7.  Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice.

Authors:  Tsuyoshi Ishikawa; Valentina M Factor; Jens U Marquardt; Chiara Raggi; Daekwan Seo; Mitsuteru Kitade; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

8.  Serum hepatocyte growth factor levels in liver diseases: clinical implications.

Authors:  G Shiota; J Okano; H Kawasaki; T Kawamoto; T Nakamura
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

9.  Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat.

Authors:  Z Hu; R P Evarts; K Fujio; E R Marsden; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

10.  Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.

Authors:  Luke Boulter; Olivier Govaere; Tom G Bird; Sorina Radulescu; Prakash Ramachandran; Antonella Pellicoro; Rachel A Ridgway; Sang Soo Seo; Bart Spee; Nico Van Rooijen; Owen J Sansom; John P Iredale; Sally Lowell; Tania Roskams; Stuart J Forbes
Journal:  Nat Med       Date:  2012-03-04       Impact factor: 53.440

View more
  1 in total

1.  Effect of cryopreservation on the appearance and liver function of hepatocyte-like cells in cultures of cirrhotic liver of biliary atresia.

Authors:  Taisuke Yamazaki; Shin Enosawa; Takayoshi Tokiwa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-05-04       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.